Call +44 (0)1904 798634 or +44 (0)7550 079918

Leading provider of life science market reports and research services

Whole Genome and Exome Sequencing Markets By Research, Clinical, Direct to Consumer, AgriBio and Tumor including Test Price and Volume Forecasts with Executive and Consultant Guides 2019 - 2023

Be the first to review this product

"WGS costs plummet. Industry on verge of mainstream breakout into Healthcare, Consumer and Agricultural Markets. Tumor Cell Sequencing a special area of interest in the battle against cancer.  A new industry emerges.”

You can choose to pay by purchase order during checkout

Availability: In stock

$5,995.00

* Required Fields

You can choose to pay by purchase order during checkout
Howe Sound Research

Digital downloads direct to your inbox within 24 hours.

First class customer service from our team of experts.

Pay by credit card or request an invoice

Product Description

Details

Updated June 20, 2018

Includes supplementary Excel file containing more than 800 locations with high-throughput sequencing instrumentation installed, providing details of systems by name, and number of systems installed

Table of Contents

Whole Genome Sequencing costs plummet. Industry on verge of mainstream breakout into Healthcare, Consumer and Agricultural Markets. A new industry emerges.

Will all newborns receive Whole Genome Sequencing at birth?  How fast will Direct to Consumer Testing grow?  What sequencing technology will take the lead? What’s holding the industry back?  Where are the 800+ locations that have high throughput devices?

A plummeting of costs for Whole Genome Sequencing (WGS) is creating a gold rush for market players.  New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage.  The report forecasts the market size out to 2023, and includes detailed breakouts for 14 countries and 5 regions for germline, somatic, pathogen, direct-to-consumer, agricultural and cancer markets.

Germline? Somatic? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon.  What are the issues?  Find the opportunities, and the pitfalls.  Understand growth expectations and the ultimate market forecasts for the next five years.

Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

  • B.Sc. (Chemistry) University of BC
  • M.B.A. (Finance and Policy) University of BC
  • Market Research Seminar - Burke Institute
  • Finance for Senior Executives - Harvard Business School


Additional Information

Additional Information

Publisher name Howe Sound Research
Format PDF
Page count 339
Publication date 20 Jun 2018
Table of contents

Table of Contents

Sample tables

Sample data (Brazil)

Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.